Pharma-c-wipes Toallitas De Alcohol Isopropilico 70

Isopropyl Alcohol


Kleen Test Products Corporation
Human Otc Drug
NDC 55239-554
Pharma-c-wipes Toallitas De Alcohol Isopropilico 70 also known as Isopropyl Alcohol is a human otc drug labeled by 'Kleen Test Products Corporation'. National Drug Code (NDC) number for Pharma-c-wipes Toallitas De Alcohol Isopropilico 70 is 55239-554. This drug is available in dosage form of Cloth. The names of the active, medicinal ingredients in Pharma-c-wipes Toallitas De Alcohol Isopropilico 70 drug includes Isopropyl Alcohol - 70 mL/100mL . The currest status of Pharma-c-wipes Toallitas De Alcohol Isopropilico 70 drug is Active.

Drug Information:

Drug NDC: 55239-554
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Pharma-c-wipes Toallitas De Alcohol Isopropilico 70
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Isopropyl Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Kleen Test Products Corporation
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cloth
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ISOPROPYL ALCOHOL - 70 mL/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Apr, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Kleen Test Products Corporation
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:797544
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:ND2M416302
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
55239-554-0040 PATCH in 1 CANISTER (55239-554-00) / 4.5 mL in 1 PATCH01 Apr, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Proposito antiseptico para primeros auxilios

Product Elements:

Pharma-c-wipes toallitas de alcohol isopropilico 70 isopropyl alcohol water isopropyl alcohol isopropyl alcohol

Indications and Usage:

Usos primeros auxlios para prevenir riesgo the infeccion: cortadas menores raspones quemaduras

Warnings:

Advertencias solo para uso externo inflamable mantengase alejado del fuego, llamas, calor, chispas, o equipo electrico consulte a un medico antes de usar si tiene heridas profundas o punzantes mordidas de animales quemaduras graves al utilizar este producto no utilizar en los ojos no aplique en areas grandes no utilizar por mas de una semana salvo por orden medica suspenda su uso y consulte a su medico si los sintomas persisten o empeoran. mantenganse fuera del alcance de los niños si se ingiere, busque ayuda medica o contacte a un centro de intoxicationes inmediatamente.

When Using:

Al utilizar este producto no utilizar en los ojos no aplique en areas grandes no utilizar por mas de una semana salvo por orden medica

Dosage and Administration:

Direcciones limpie el area afectada aplique el producto enel area del cuerpo afectada de 1 a 3 veces al dia se puede cubrir con venda esterilizada dejar secar el area antes de vendar

Stop Use:

Suspenda su uso y consulte a su medico si los sintomas persisten o empeoran.

Package Label Principal Display Panel:

Package labeling: label

Further Questions:

Preguntas o comentarios? 1-844-308-8600


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.